Harrow Health, Inc.
Harrow Health, Inc. (HROW) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
hrow · stock forecast · 10 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 10 Wall Street analysts in the past 3 months
Buy
10 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$88.00
Consensus
$73.67
+120.2% upside
Low
$63.00
Median: $70 · Last Close: $33.45
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$73.67
120.2% upside
High Target
$88
163.0%
Low Target
$63
88.3%
Current Price
$33.45
as of today
Based on analyst price targets, the HROW stock price prediction for the next 12 months ranges from $63 to $88. The consensus HROW price forecast of $73.67 implies 120.2% upside from the current price of $33.45.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $33.83 | ↑ 1.12% |
1-day model range: $33.52–$34.14. Peak: $34.14 (+1.12%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $42 | +26.7% |
| 2028 | $49 | +45.3% |
| 2029 | $53 | +57.0% |
| 2030 | $55 | +64.0% |
| 2031 | — | +68.0% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · HROW · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-13 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2026-05-12 | BTIG | Maintains | Buy→Buy |
| 2026-04-17 | BTIG | Maintains | Buy→Buy |
| 2026-04-07 | B. Riley Securities | Maintains | Buy→Buy |
| 2026-03-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-18 | BTIG | Maintains | Buy→Buy |
| 2026-03-04 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2026-03-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-12 | Ladenburg Thalmann | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Harrow Health, Inc. (HROW) stock. Of the recent 46 rating actions, 0 were upgrades and 0 were downgrades. 10 analysts currently cover HROW.
Analyst Recommendation Trends
HROW analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 7 to 2 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$348M
↓ 52.2% YoY
Revenue Next Year
$516M
↑ 48.0% YoY
EPS This Year
$0.25
EPS Next Year
$2.31
↑ 831.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast HROW EPS of $0.25 for the current fiscal year, based on estimates from 5 analysts. The HROW revenue forecast is $348M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The HROW stock forecast is supported by two independent data sources: analyst consensus ratings from 10 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus HROW price target is $73.67 (+120.2% upside), with an analyst consensus of Buy.
The HROW short-term stock prediction for tomorrow is $33.83 (+1.12%). The HROW stock price prediction for 2027 estimates an average of $42. The HROW stock prediction for 2030 projects a range of $49–$60.
Harrow Health, Inc. trades on NASDAQ under the ticker HROW. The HROW stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
HROW forecast · 8 questionsAccording to 10 Wall Street analysts, the average 12-month HROW price target is $73.67, with a high forecast of $88.00 and a low of $63.00. The median price target is shown in the chart above when available. This implies +120.2% potential upside from the current price of $33.45.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.